SS
DFTX

SBI Securities’s Definium Therapeutics DFTX Stock Holding History

SBI Securities’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.85K Buy
98
+7
+8% +$119 ﹤0.01% 2445
2025
Q4 		$1.22K Sell
91
-14
-13% -$173 ﹤0.01% 2571
2025
Q3 		$1.24K Sell
105
-277
-73% -$2.58K ﹤0.01% 2606
2025
Q2 		$2.48K Buy
382
+76
+25% +$500 ﹤0.01% 2300
2025
Q1 		$1.79K Buy
306
+110
+56% +$788 ﹤0.01% 2340
2024
Q4 		$1.36K Buy
+196
New +$1.35K ﹤0.01% 2471

Other funds holding DFTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SBI Securities's DFTX Position: Q1 2026 in Review

SBI Securities increased its Definium Therapeutics (DFTX) stake by 7.7% in Q1 2026, buying an estimated $119 and bringing the position to 98 shares worth $1.85K. The position accounts for ﹤0.01% of the portfolio, ranked #2445.

SBI Securities first reported a position in DFTX in Q4 2024 and has held it in 6 quarters since. The position peaked at $2.48K in Q2 2025. 247 funds tracked by Wall St. Rank hold DFTX as of Q1 2026.

  • SBI Securities held 98 shares of Definium Therapeutics worth $1.85K as of Q1 2026.
  • SBI Securities bought 7 Definium Therapeutics shares in Q1 2026, an estimated $119.
  • Definium Therapeutics made up ﹤0.01% of SBI Securities's portfolio in Q1 2026, its #2445 holding.
  • SBI Securities first reported a position in Definium Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • SBI Securities's Definium Therapeutics position peaked at $2.48K in Q2 2025.
  • 247 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2026.

Based on SBI Securities's 13F filing for Q1 2026, filed 28 Apr 2026.